FDA NDC Directory · JSON-LD · Markdown

EMFLAZA

NDC 52856-504 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namedeflazacort
Labeler / ManufacturerPTC Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208684
Dosage form / routeTABLET · ORAL
Active ingredientsDEFLAZACORT (36 mg/1)
Marketing started20180910
Package count1

External sources

Source: openFDA. Public-domain (CC0).